InvestorQ : What is the status of other problems that Indian pharma is already facing like the USFDA problem? Does the China problem add to those problems for likes of Aurobindo?

What is the status of other problems that Indian pharma is already facing like the USFDA problem? Does the China problem add to those problems for likes of Aurobindo?

Fundamentals,Market View

No More Feeds Available